Intratracheal recombinant human deoxyribonuclease in acute life-threatening asthma refractory to conventional treatment
- PMID: 10823105
- DOI: 10.1093/oxfordjournals.bja.a013479
Intratracheal recombinant human deoxyribonuclease in acute life-threatening asthma refractory to conventional treatment
Abstract
Recombinant human deoxyribonuclease (rhDNase) is a mucolytic agent used to relieve peripheral airway obstruction in patients with cystic fibrosis. We report dramatic sustained improvement following the intratracheal administration of rhDNase to a 3-yr-old boy with acute life-threatening asthma in whom 48 h of aggressive therapy had failed.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical